| 标题 |
Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third‐line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP‐4 inhibitors: A multicentre, phase 4 randomized controlled trial 吡格列酮、恩格列净和格列美脲作为三线药物治疗二甲双胍和DPP-4抑制剂控制不佳的2型糖尿病患者的疗效和安全性:一项多中心、4期随机对照试验
|
| 网址 | |
| DOI | |
| 其它 |
期刊:Diabetes, Obesity and Metabolism 作者:Yun Kyung Cho; Jae‐Hyoung Cho; Sang‐Mo Hong; Jung Hwan Park; Byung‐Wan Lee; et al 出版日期:2025 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |